| 10:00 |
Introduction par Luc Buée et Jean-Charles Lambert. |
| 10:10 |
Clinical and translational proteomic: The SELDI pathway.
Rémi Bocquentin, M.Sc., (Ciphergen, Paris) |
| 10:55 |
Affymetrix GeneChips for Genotyping and Resequencing.
Dr. Seamus O'Regan (Field Applications Specialist, Affymetrix Europe) |
| 11:40 |
New Alzheimer disease markers, discovery and pre-validation using SELDI approaches.
Dr. Huw Davies (Biomarker Discovery Center, Copenhagen, Denmark - Responsable du programme neurosciences Ciphergen) |
| 12:25 |
Déjeuner-Buffet offert par la Société Affymetrix |
| 13:45 |
Combining genetic labeling and laser microdissection for the global transcriptome analysis of defined neuronal cell types.
Dr. Moritz J. Rossner (Max-Planck-Institute for Experimental Medicine, Goettingen, Germany) |
| 14:30 |
Central and peripheral biomarkers in diseases: A SELDI-TOF approach.
Dr. Eugeen Vanmechelen / Vesna Kostanjevecki (Innogenetics, Gent, Belgium) |
| 15:15 |
Candidate genes in neurodegenerative disorders: Relevance and limitation of the transcriptomic approach.
Dr. Jean-Charles Lambert (INSERM U508/IPL, Lille) |
| 16:00 |
Applications of SELDI-TOF to Neurosciences: Clinical and pre-clinical aspects.
Dr. François Berger (INSERM U318, Grenoble) |
| 16:45 |
Conclusions |
| 17:00 |
Fin de l'atelier |